BMC Neurol

1. VASIREDDY S, Biswas S, Kollu R, Krishnan E, et al
   Comparative effectiveness and safety of preventive treatments for vestibular migraine: a systematic review and network meta-analysis.
   BMC Neurol. 2025;25:513.
   

   >> Share

   
   

   
   Cephalalgia

2. ASHINA M, Tassorelli C, Kokturk P, Akcicek H, et al
   Addressing unmet needs in migraine: Real-world fremanezumab effectiveness in participants of the PEARL study with at least three prior preventive treatment failures.
   Cephalalgia. 2025;45:3331024251395029.
   

   >> Share

   
   

   
   Headache

3. CHENG N, Anderson CC, Zhang N, VanderPluym JH, et al
   Remote electrical neuromodulation for reducing procedural pain in patients with chronic migraine receiving onabotulinumtoxinA injections: A randomized sham-controlled study.
   Headache. 2025 Dec 31. doi: 10.1111/head.70032.
   

   >> Share

   
   
4. SCHUSTER NM, Wallace MS, Marcotte TD, Buse DC, et al
   Vaporized cannabis versus placebo for acute migraine: A randomized, double-blind, placebo-controlled crossover trial.
   Headache. 2025 Dec 30. doi: 10.1111/head.70025.
   

   >> Share

   
   
5. GRANT TEJADA MP, Klomhaus AM, Ortiz R, Tibbe TD, et al
   Migraine prevalence and phenotype in autism: A retrospective cohort study using a US National Health Survey and large academic health system electronic health record.
   Headache. 2025 Dec 29. doi: 10.1111/head.70035.
   

   >> Share

   
   
6. SCHINDLER EAD, Gottschalk CH, Pittman BP, D'Souza DC, et al
   Comparing single- and repeat-dose psilocybin with active placebo for migraine prevention in an exploratory randomized controlled clinical trial.
   Headache. 2025 Dec 29. doi: 10.1111/head.70024.
   

   >> Share

   
   

   
   Rev Neurol (Paris)

7. HASIRCI BAYIR BR, Ulutas C, Nazli E, Koklu H, et al
   The role of kynurenine pathway metabolites in clinical features and chronic migraine.
   Rev Neurol (Paris). 2025 Dec 24:S0035-3787(25)00657.
   

   >> Share

   
   
8. HENRI J, Redon S, Donnet A
   Refining the definition of severe migraine: Evidence from a prospective observational study.
   Rev Neurol (Paris). 2025 Dec 22:S0035-3787(25)00658.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share